News
ACHA ACHD Accreditation Found to Improve Patient Survival While Waiting for Heart Transplant
ACHA ACHD Program Accreditation continues to develop and grow with 34 fully accredited programs and several more initiating and completing the process. Programs of all sizes—with widespread geographic locations and various care models—have met the criteria to become fully accredited. The ACHA Accreditation Program was designed and developed by providers and patients to meet the needs of the ACHD patient population and improve the quality of care delivered throughout the United States.
ACHA to Recognize Evan Michael Zahn, MD, for Contributions to Congenital Interventional Cardiology
The Adult Congenital Heart Association (ACHA) has announced Evan Michael Zahn, MD, professor of Pediatrics and Director of the Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai, as its honoree for the organization’s Los Angeles Benefit on November 2. Dr. Zahn will be honored for his contributions to the field of adult congenital cardiology during a fundraiser from 1 p.m. to 4 p.m. at the Propagator, part of Firestone Walker Brewing Company, in Marina Del Rey.
ACHD National Registry Survey Responses Needed
Development of a patient-driven adult congenital heart disease national registry is in progress and your feedback is needed on surveys that will be used to assess patient reported outcomes on overall health and well-being.
Board of Directors Recruitment Period Opens
The Adult Congenital Heart Association is currently recruiting highly-qualified candidates to serve on the ACHA Board of Directors (BOD). To learn more about the roles, responsibilities and qualifications for our BOD, please click here.
Medical Advisory Board Recruitment Period Opens
The Adult Congenital Heart Association is currently recruiting Medical Advisory Board (MAB) members. The term for this round of MAB members will begin on January 1, 2020, and run for three years.
ACHA Announces Funding of Organization’s Inaugural Research Grants
The Adult Congenital Heart Association (ACHA) has funded six research grants to advance the science of congenital heart disease (CHD) in adults. With the advent of this new ACHA program, the organization aims to improve the lives of CHD patients and future generations in partnership with medical professionals.
“If it were not for medical research and innovation, adult congenital heart disease (ACHD) would not exist as a field,” says Jamil Aboulhosn, MD, FACC, FSCAI, ACHA Medical Advisory Board Chair, noting that in the textbooks of the early 20th century, there was barely a mention of CHD. “There are so many questions that are still unasked and unanswered in this field and it is imperative that we do our part to move things forward, and that can only happen through research and innovation.”
Join our D.C. Advocates and Participate from Home on Tuesday, March 5!
On Tuesday, March 5, nearly 200 fellow advocates will be on Capitol Hill meeting with their Members of Congress as part of the 2018 Congenital Heart Legislative Conference.
They are asking their lawmakers to support research, data collection and awareness activities related to congenital heart disease (CHD), and to support the more than 2.4 million Americans living with the lifelong consequences of congenital heart disease.
We need you to participate from home!
The ACHA Discussion Forum is Now Our New Online Community
We are excited to launch our new Online Community, which provides our members with opportunities to connect with one another and ACHA! All information from the previous Discussion Forum you've known for years has been transferred to our new Online Community, including usernames and passwords.
Introducing Walk for 1 in 100
We are so excited to share our brand new fundraising campaign with our members and the congenital heart disease (CHD) community! We hope you will join us this year as we walk for the 1 in 100 children and adults impacted by CHD across the country.
In 2019, we will be introducing Walk for 1 in 100 in 14 communities to raise money for outreach, education, research and more. Our events were created to empower all of those living with CHD, their loved ones, and the medical community that cares for them.
Congenital Heart Futures Reauthorization Act
Today, there was final passage of the Congenital Heart Futures Reauthorization Act in the House of Representatives! ACHA’s sincere thanks go to Representatives Bilirakis and Schiff, Senators Durbin and Young and their staffs, for their tireless work that enabled passage of the bill. The bill now goes to President Trump for his signature.